Shai Mulinari

Associate Professor , Senior Lecturer, , , , , , , , , Ph D, Master of Science
More filtering options
  1. 2020
  2. Sociologiska perspektiv på coronakrisen: Fyra sociologer om samhällets reaktion på covid-19

    Danielsson, E., Liljeros, F., Shai Mulinari & Soneryd, L., 2020 Apr 8, In : Sociologisk Forskning. 57, 1, p. 67-76

    Research output: Contribution to journalLetter

  3. The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza

    Shai Mulinari & Davis, C., 2020 Jan 24, In : Social Studies of Science. 50, 1, p. 145-169 25 p.

    Research output: Contribution to journalArticle

  4. Ras i genetikens tidevarv

    Barot, S., Bredström, A., Shai Mulinari & Shutzberg, M., 2020, Fronesis, 66-67, p. 8-17 9 p.

    Research output: Contribution to specialist publication or newspaperSpecialist publication article

  5. Ras och genetiska skillnader: Introduktion till avsnittets texter

    Shai Mulinari, 2020, Fronesis, 66-67, p. 20-23 4 p.

    Research output: Contribution to specialist publication or newspaperSpecialist publication article

  6. Svenska gener? Om stratifierad precisionsmedicin och genetikens etniska gränsdragningar

    Bredström, A. & Shai Mulinari, 2020, Fronesis, 66-67, p. 65-81.

    Research output: Contribution to specialist publication or newspaperSpecialist publication article

  7. 2019
  8. The whistleblowing drama behind Astellas’s suspension from the ABPI

    Cohen, D., Shai Mulinari & Ozieranski, P., 2019 Jul 2, In : BMJ: British Medical Journal. 366, 1453.

    Research output: Contribution to journalLetter

  9. Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

    Ozieranski, P., Csanadi, M., Rickard, E., Tchilingirian, J. & Shai Mulinari, 2019 Jun 21, In : JAMA Network Open. 2, 6, p. e196253

    Research output: Contribution to journalArticle

  10. Exposing drug industry funding of UK patient organisations

    Ozieranski, P., Richard, E. & Shai Mulinari, 2019 May 23, In : BMJ: British Medical Journal. 365, l1806 .

    Research output: Contribution to journalArticle

  11. Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

    Richard, E., Ozieranski, P. & Shai Mulinari, 2019, In : Health Policy. 123, 12, p. 1244-1250

    Research output: Contribution to journalArticle

  12. 2018
  13. Explaining biological depression theories

    Shai Mulinari, 2018 Dec 6, In : Philosophy, Psychiatry, and Psychology. 4, 25, p. 309-310 2 p.

    Research output: Contribution to journalLetter

  14. Let the drugs lead the way! On the unfolding of a research programme in psychiatry

    Shai Mulinari, 2018 Dec 6, In : Philosophy, Psychiatry, and Psychology. 4, 25, p. 289-302 13 p.

    Research output: Contribution to journalArticle

  15. Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data

    Bjerkeli, P. J., Raquel Perez Vicente, Shai Mulinari, Johnell, K. & Juan Merlo, 2018 Nov 9, In : Clinical Epidemiology. 10, p. 1657-1665 9 p.

    Research output: Contribution to journalArticle

  16. Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries

    Fabbri, A., Santos, A. L., Mezinska, S., Shai Mulinari & Mintzes, B., 2018 Jun, In : International Journal of Health Policy and Management. 7, 6, p. 504-509 6 p.

    Research output: Contribution to journalArticle

  17. Categorical and anti-categorical approaches to US racial/ethnic groupings: revisiting the National 2009 H1N1 Flu Survey (NHFS)

    Shai Mulinari, Maria Wemrell, Rönnerstrand, B., Subramanian, SV. & Juan Merlo, 2018, In : Critical Public Health. 28, 2, p. 177-189

    Research output: Contribution to journalArticle

  18. 2017
  19. Intersektionalitet och risk för ischemisk hjärtsjukdom i Sverige

    Maria Wemrell, Shai Mulinari & Juan Merlo, 2017 Mar 7, BestPractice Diabetes / Hjärtkärlsjukdomar i Sverige, 2017, Mars.

    Research output: Contribution to specialist publication or newspaperSpecialist publication article

  20. 2016
  21. Hail the Tattletale

    Shai Mulinari, 2016 Feb 3, The Medicine Maker, p. 503-506.

    Research output: Contribution to specialist publication or newspaperNewspaper article

  22. 2015
  23. Etik och marknadsföring: Skäl till självkritik?

    Shai Mulinari, 2015, Pharma Industry, 2, 15, p. 28-30.

    Research output: Contribution to specialist publication or newspaperSpecialist publication article

  24. Många allvarliga brott mot regler när läkemedel marknadsförs

    Shai Mulinari, 2015, In : Läkartidningen. 112, 14-15, p. 703

    Research output: Contribution to journalLetter

  25. Money, Money, Money? Politico-Moral Discourses of Stem Cell Research in a Grant Allocation Process

    Shai Mulinari, Holmberg, T. & Ideland, M., 2015, In : Science & Technology Studies. 28, 2, p. 53-72

    Research output: Contribution to journalArticle

  26. Replik, etik och marknadsföring: Inte för sent för reformer

    Shai Mulinari, 2015, In : Läkartidningen. 112, DF3C

    Research output: Contribution to journalLetter

  27. 2014
  28. 2013
  29. Misleading advertising for antidepressants in sweden: a failure of pharmaceutical industry self-regulation.

    Zetterqvist, A. & Shai Mulinari, 2013, In : PLoS ONE. 8, 5, e62609.

    Research output: Contribution to journalArticle

  30. 2012
Previous 1 2 Next